151 related articles for article (PubMed ID: 22168458)
1. Peroxisome proliferator-activated receptor α (PPARα) mRNA expression in human hepatocellular carcinoma tissue and non-cancerous liver tissue.
Kurokawa T; Shimomura Y; Bajotto G; Kotake K; Arikawa T; Ito N; Yasuda A; Nagata H; Nonami T; Masuko K
World J Surg Oncol; 2011 Dec; 9():167. PubMed ID: 22168458
[TBL] [Abstract][Full Text] [Related]
2. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.
Thomas M; Bayha C; Klein K; Müller S; Weiss TS; Schwab M; Zanger UM
BMC Cancer; 2015 Jun; 15():488. PubMed ID: 26122096
[TBL] [Abstract][Full Text] [Related]
3. Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines.
König B; Eder K
J Nutr Biochem; 2006 Jun; 17(6):410-8. PubMed ID: 16216487
[TBL] [Abstract][Full Text] [Related]
4. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC
Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
[TBL] [Abstract][Full Text] [Related]
6. E
Chang-Lee SN; Hsu HH; Shibu MA; Ho TJ; Tsai CH; Chen MC; Tu CC; Viswanadha VP; Kuo WW; Huang CY
Pathol Oncol Res; 2017 Jul; 23(3):477-485. PubMed ID: 27757837
[TBL] [Abstract][Full Text] [Related]
7. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
Dharancy S; Malapel M; Perlemuter G; Roskams T; Cheng Y; Dubuquoy L; Podevin P; Conti F; Canva V; Philippe D; Gambiez L; Mathurin P; Paris JC; Schoonjans K; Calmus Y; Pol S; Auwerx J; Desreumaux P
Gastroenterology; 2005 Feb; 128(2):334-42. PubMed ID: 15685545
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
[TBL] [Abstract][Full Text] [Related]
9. Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice.
Meyer K; Jia Y; Cao WQ; Kashireddy P; Rao MS
Int J Oncol; 2002 Dec; 21(6):1175-80. PubMed ID: 12429965
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma.
Kijima H; Sawada T; Tomosugi N; Kubota K
BMC Cancer; 2008 Jun; 8():167. PubMed ID: 18541040
[TBL] [Abstract][Full Text] [Related]
11. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
Peng SY; Chou SP; Hsu HC
J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.
Cheng Y; Dharancy S; Malapel M; Desreumaux P
World J Gastroenterol; 2005 Dec; 11(48):7591-6. PubMed ID: 16437683
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.
Shah YM; Morimura K; Yang Q; Tanabe T; Takagi M; Gonzalez FJ
Mol Cell Biol; 2007 Jun; 27(12):4238-47. PubMed ID: 17438130
[TBL] [Abstract][Full Text] [Related]
14. Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma.
Andrejeva D; Kugler JM; Nguyen HT; Malmendal A; Holm ML; Toft BG; Loya AC; Cohen SM
BMC Cancer; 2018 Nov; 18(1):1180. PubMed ID: 30486822
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma.
Liu R; Zhang H; Zhang Y; Li S; Wang X; Wang X; Wang C; Liu B; Zen K; Zhang CY; Zhang C; Ba Y
Tumour Biol; 2017 Apr; 39(4):1010428317695031. PubMed ID: 28381162
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements.
Song S; Attia RR; Connaughton S; Niesen MI; Ness GC; Elam MB; Hori RT; Cook GA; Park EA
Mol Cell Endocrinol; 2010 Aug; 325(1-2):54-63. PubMed ID: 20638986
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.
Xie G; Yin S; Zhang Z; Qi D; Wang X; Kim D; Yagai T; Brocker CN; Wang Y; Gonzalez FJ; Wang H; Qu A
Am J Pathol; 2019 Feb; 189(2):272-282. PubMed ID: 30448405
[TBL] [Abstract][Full Text] [Related]
19. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
20. The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma.
Wang Q; Shen Y; Wang P; Li X
J Cancer Res Ther; 2013; 9(2):250-2. PubMed ID: 23771368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
